p roject management (d ashboard and m etrics ) with q lik v iew s tÉphane p irault k eyrus - b...
TRANSCRIPT
![Page 1: P ROJECT MANAGEMENT (D ASHBOARD AND M ETRICS ) WITH Q LIK V IEW S TÉPHANE P IRAULT K EYRUS - B IOPHARMA P HUSE 2010 – B ERLIN](https://reader036.vdocuments.site/reader036/viewer/2022070305/55145757550346284e8b5425/html5/thumbnails/1.jpg)
PROJECT MANAGEMENT (DASHBOARD AND METRICS) WITH QLIKVIEW
STÉPHANE PIRAULTKEYRUS - BIOPHARMA
PHUSE 2010 – BERLIN PHUSE 2010 – BERLIN
![Page 2: P ROJECT MANAGEMENT (D ASHBOARD AND M ETRICS ) WITH Q LIK V IEW S TÉPHANE P IRAULT K EYRUS - B IOPHARMA P HUSE 2010 – B ERLIN](https://reader036.vdocuments.site/reader036/viewer/2022070305/55145757550346284e8b5425/html5/thumbnails/2.jpg)
OUTLINE OUTLINE
OBJECTIVE OF THE SOLUTIONOBJECTIVE OF THE SOLUTION
THE SOURCE DATATHE SOURCE DATA
THE IMPORT OF SOURCE DATATHE IMPORT OF SOURCE DATA
CONCEPTION OF THE INFORMATION MONITORING TAB CONCEPTION OF THE INFORMATION MONITORING TAB
CONCLUSIONCONCLUSION
LINICAL A KEYRUS BIOPHARMA SOLUTIONLINICAL A KEYRUS BIOPHARMA SOLUTION
![Page 3: P ROJECT MANAGEMENT (D ASHBOARD AND M ETRICS ) WITH Q LIK V IEW S TÉPHANE P IRAULT K EYRUS - B IOPHARMA P HUSE 2010 – B ERLIN](https://reader036.vdocuments.site/reader036/viewer/2022070305/55145757550346284e8b5425/html5/thumbnails/3.jpg)
OBJECTIVE OBJECTIVE
CENTRALISED APPLICATIONCENTRALISED APPLICATION
PROVIDES MONITORING INDICATORSPROVIDES MONITORING INDICATORS
MUST ALSO MEET THE SAFETY REQUIREMENTS OF CLINICAL TRIAL DATAMUST ALSO MEET THE SAFETY REQUIREMENTS OF CLINICAL TRIAL DATA
ASSISTS IN THE PLANNING AND PERFORMANCE OF MONITORING VISITSASSISTS IN THE PLANNING AND PERFORMANCE OF MONITORING VISITS
EASY TO USEEASY TO USE
![Page 4: P ROJECT MANAGEMENT (D ASHBOARD AND M ETRICS ) WITH Q LIK V IEW S TÉPHANE P IRAULT K EYRUS - B IOPHARMA P HUSE 2010 – B ERLIN](https://reader036.vdocuments.site/reader036/viewer/2022070305/55145757550346284e8b5425/html5/thumbnails/4.jpg)
THE SOURCE DATATHE SOURCE DATA
![Page 5: P ROJECT MANAGEMENT (D ASHBOARD AND M ETRICS ) WITH Q LIK V IEW S TÉPHANE P IRAULT K EYRUS - B IOPHARMA P HUSE 2010 – B ERLIN](https://reader036.vdocuments.site/reader036/viewer/2022070305/55145757550346284e8b5425/html5/thumbnails/5.jpg)
IMPORT OF SOURCE DATA : ODBC (1)IMPORT OF SOURCE DATA : ODBC (1)
![Page 6: P ROJECT MANAGEMENT (D ASHBOARD AND M ETRICS ) WITH Q LIK V IEW S TÉPHANE P IRAULT K EYRUS - B IOPHARMA P HUSE 2010 – B ERLIN](https://reader036.vdocuments.site/reader036/viewer/2022070305/55145757550346284e8b5425/html5/thumbnails/6.jpg)
IMPORT OF SOURCE DATA : IMPORT OF SOURCE DATA : THE SCRIPTTHE SCRIPT
SET ThousandSep=' ';SET DecimalSep='.';SET MoneyThousandSep=' ';SET MoneyDecimalSep=',';SET MoneyFormat='# ##0,00 €;-# ##0,00 €';SET TimeFormat='hh:mm:ss';SET DateFormat='DD/MM/YYYY';SET TimestampFormat='DD/MM/YYYY hh:mm:ss[.fff]';
SET MonthNames='janv.;févr.;mars;avr.;mai;juin;juil.;août;sept.;oct.;nov.;déc.';SET DayNames='lun.;mar.;mer.;jeu.;ven.;sam.;dim.';
ODBC CONNECT TO [Excel Files;DBQ=C:\Qlikview\Projets QV Paris\DATA\Outils recherche clinique English QV.xls];
SQL SELECT *FROM `C:\Qlikview\Projets QV Paris\DATA\Outils recherche clinique English QV.xls`.`Centre$`;;//************************************************SQL SELECT *FROM `C:\Qlikview\Projets QV Paris\DATA\Outils recherche clinique English QV.xls`.`Patient$`;;//************************************************
………
//************************************************Alertes:SQL SELECT patient_nb as patient_nb_alerte, date_monitoring as date_monito_alerte, centre_nb & ' (date monitoring : ' & date_monitoring & ')' as centre_monito_alerteFROM `C:\Qlikview\Projets QV Paris\DATA\Outils recherche clinique English QV.xls`.`Patient$` where date_monitoring is not null and date_envoi is null;;//************************************************
![Page 7: P ROJECT MANAGEMENT (D ASHBOARD AND M ETRICS ) WITH Q LIK V IEW S TÉPHANE P IRAULT K EYRUS - B IOPHARMA P HUSE 2010 – B ERLIN](https://reader036.vdocuments.site/reader036/viewer/2022070305/55145757550346284e8b5425/html5/thumbnails/7.jpg)
CONCEPTION OF THE CONCEPTION OF THE INFORMATION MONITORING TABINFORMATION MONITORING TAB
![Page 8: P ROJECT MANAGEMENT (D ASHBOARD AND M ETRICS ) WITH Q LIK V IEW S TÉPHANE P IRAULT K EYRUS - B IOPHARMA P HUSE 2010 – B ERLIN](https://reader036.vdocuments.site/reader036/viewer/2022070305/55145757550346284e8b5425/html5/thumbnails/8.jpg)
CREATION OF NEW TABCREATION OF NEW TAB
INSTANT INSTANT INFORMATIINFORMATI
ONON
NOT NOT EXPANDABLE EXPANDABLE
SCREEN SCREEN
DESIDESIGN GN
![Page 9: P ROJECT MANAGEMENT (D ASHBOARD AND M ETRICS ) WITH Q LIK V IEW S TÉPHANE P IRAULT K EYRUS - B IOPHARMA P HUSE 2010 – B ERLIN](https://reader036.vdocuments.site/reader036/viewer/2022070305/55145757550346284e8b5425/html5/thumbnails/9.jpg)
Current Selection
Visit Status
OBJECT CREATION (1)OBJECT CREATION (1)
![Page 10: P ROJECT MANAGEMENT (D ASHBOARD AND M ETRICS ) WITH Q LIK V IEW S TÉPHANE P IRAULT K EYRUS - B IOPHARMA P HUSE 2010 – B ERLIN](https://reader036.vdocuments.site/reader036/viewer/2022070305/55145757550346284e8b5425/html5/thumbnails/10.jpg)
OBJECT CREATION (2)OBJECT CREATION (2)
![Page 11: P ROJECT MANAGEMENT (D ASHBOARD AND M ETRICS ) WITH Q LIK V IEW S TÉPHANE P IRAULT K EYRUS - B IOPHARMA P HUSE 2010 – B ERLIN](https://reader036.vdocuments.site/reader036/viewer/2022070305/55145757550346284e8b5425/html5/thumbnails/11.jpg)
OBJECT CREATION (3)OBJECT CREATION (3)
![Page 12: P ROJECT MANAGEMENT (D ASHBOARD AND M ETRICS ) WITH Q LIK V IEW S TÉPHANE P IRAULT K EYRUS - B IOPHARMA P HUSE 2010 – B ERLIN](https://reader036.vdocuments.site/reader036/viewer/2022070305/55145757550346284e8b5425/html5/thumbnails/12.jpg)
OBJECT CREATION (4)OBJECT CREATION (4)
![Page 13: P ROJECT MANAGEMENT (D ASHBOARD AND M ETRICS ) WITH Q LIK V IEW S TÉPHANE P IRAULT K EYRUS - B IOPHARMA P HUSE 2010 – B ERLIN](https://reader036.vdocuments.site/reader036/viewer/2022070305/55145757550346284e8b5425/html5/thumbnails/13.jpg)
OBJECT CREATION (5)OBJECT CREATION (5)
![Page 14: P ROJECT MANAGEMENT (D ASHBOARD AND M ETRICS ) WITH Q LIK V IEW S TÉPHANE P IRAULT K EYRUS - B IOPHARMA P HUSE 2010 – B ERLIN](https://reader036.vdocuments.site/reader036/viewer/2022070305/55145757550346284e8b5425/html5/thumbnails/14.jpg)
TAB DESIGN (1)TAB DESIGN (1)
![Page 15: P ROJECT MANAGEMENT (D ASHBOARD AND M ETRICS ) WITH Q LIK V IEW S TÉPHANE P IRAULT K EYRUS - B IOPHARMA P HUSE 2010 – B ERLIN](https://reader036.vdocuments.site/reader036/viewer/2022070305/55145757550346284e8b5425/html5/thumbnails/15.jpg)
TAB DESIGN (2)TAB DESIGN (2)
![Page 16: P ROJECT MANAGEMENT (D ASHBOARD AND M ETRICS ) WITH Q LIK V IEW S TÉPHANE P IRAULT K EYRUS - B IOPHARMA P HUSE 2010 – B ERLIN](https://reader036.vdocuments.site/reader036/viewer/2022070305/55145757550346284e8b5425/html5/thumbnails/16.jpg)
TAB DESIGN (3)TAB DESIGN (3)
![Page 17: P ROJECT MANAGEMENT (D ASHBOARD AND M ETRICS ) WITH Q LIK V IEW S TÉPHANE P IRAULT K EYRUS - B IOPHARMA P HUSE 2010 – B ERLIN](https://reader036.vdocuments.site/reader036/viewer/2022070305/55145757550346284e8b5425/html5/thumbnails/17.jpg)
TAB DESIGN (4)TAB DESIGN (4)
![Page 18: P ROJECT MANAGEMENT (D ASHBOARD AND M ETRICS ) WITH Q LIK V IEW S TÉPHANE P IRAULT K EYRUS - B IOPHARMA P HUSE 2010 – B ERLIN](https://reader036.vdocuments.site/reader036/viewer/2022070305/55145757550346284e8b5425/html5/thumbnails/18.jpg)
HOW TO USE THE TAB (1) ?HOW TO USE THE TAB (1) ?
![Page 19: P ROJECT MANAGEMENT (D ASHBOARD AND M ETRICS ) WITH Q LIK V IEW S TÉPHANE P IRAULT K EYRUS - B IOPHARMA P HUSE 2010 – B ERLIN](https://reader036.vdocuments.site/reader036/viewer/2022070305/55145757550346284e8b5425/html5/thumbnails/19.jpg)
HOW TO USE THE TAB (2) ?HOW TO USE THE TAB (2) ?
![Page 20: P ROJECT MANAGEMENT (D ASHBOARD AND M ETRICS ) WITH Q LIK V IEW S TÉPHANE P IRAULT K EYRUS - B IOPHARMA P HUSE 2010 – B ERLIN](https://reader036.vdocuments.site/reader036/viewer/2022070305/55145757550346284e8b5425/html5/thumbnails/20.jpg)
LINICALLINICAL
KEYRUS BIOPHARMA KEYRUS BIOPHARMA SOLUTIONSOLUTION
![Page 21: P ROJECT MANAGEMENT (D ASHBOARD AND M ETRICS ) WITH Q LIK V IEW S TÉPHANE P IRAULT K EYRUS - B IOPHARMA P HUSE 2010 – B ERLIN](https://reader036.vdocuments.site/reader036/viewer/2022070305/55145757550346284e8b5425/html5/thumbnails/21.jpg)
CONTENTS OF THE SOLUTIONCONTENTS OF THE SOLUTION
HOME PAGEHOME PAGE
DASHBOARDDASHBOARD
CENTER STATISTICSCENTER STATISTICS
CENTER INFORMATIONCENTER INFORMATION
COUNTRY STATISTICSCOUNTRY STATISTICS
INFORMATION MONITORINGINFORMATION MONITORING
SAESAE
FINANCIAL INFORMATIONFINANCIAL INFORMATION
HELPHELP
![Page 22: P ROJECT MANAGEMENT (D ASHBOARD AND M ETRICS ) WITH Q LIK V IEW S TÉPHANE P IRAULT K EYRUS - B IOPHARMA P HUSE 2010 – B ERLIN](https://reader036.vdocuments.site/reader036/viewer/2022070305/55145757550346284e8b5425/html5/thumbnails/22.jpg)
HOME PAGE TABHOME PAGE TAB
![Page 23: P ROJECT MANAGEMENT (D ASHBOARD AND M ETRICS ) WITH Q LIK V IEW S TÉPHANE P IRAULT K EYRUS - B IOPHARMA P HUSE 2010 – B ERLIN](https://reader036.vdocuments.site/reader036/viewer/2022070305/55145757550346284e8b5425/html5/thumbnails/23.jpg)
DASHBOARD TABDASHBOARD TAB
![Page 24: P ROJECT MANAGEMENT (D ASHBOARD AND M ETRICS ) WITH Q LIK V IEW S TÉPHANE P IRAULT K EYRUS - B IOPHARMA P HUSE 2010 – B ERLIN](https://reader036.vdocuments.site/reader036/viewer/2022070305/55145757550346284e8b5425/html5/thumbnails/24.jpg)
CENTER INFORMATION TABCENTER INFORMATION TAB
![Page 25: P ROJECT MANAGEMENT (D ASHBOARD AND M ETRICS ) WITH Q LIK V IEW S TÉPHANE P IRAULT K EYRUS - B IOPHARMA P HUSE 2010 – B ERLIN](https://reader036.vdocuments.site/reader036/viewer/2022070305/55145757550346284e8b5425/html5/thumbnails/25.jpg)
CENTER INFORMATION TABCENTER INFORMATION TAB
![Page 26: P ROJECT MANAGEMENT (D ASHBOARD AND M ETRICS ) WITH Q LIK V IEW S TÉPHANE P IRAULT K EYRUS - B IOPHARMA P HUSE 2010 – B ERLIN](https://reader036.vdocuments.site/reader036/viewer/2022070305/55145757550346284e8b5425/html5/thumbnails/26.jpg)
CENTER STATISITICS TABCENTER STATISITICS TAB
![Page 27: P ROJECT MANAGEMENT (D ASHBOARD AND M ETRICS ) WITH Q LIK V IEW S TÉPHANE P IRAULT K EYRUS - B IOPHARMA P HUSE 2010 – B ERLIN](https://reader036.vdocuments.site/reader036/viewer/2022070305/55145757550346284e8b5425/html5/thumbnails/27.jpg)
HELP TABHELP TAB
![Page 28: P ROJECT MANAGEMENT (D ASHBOARD AND M ETRICS ) WITH Q LIK V IEW S TÉPHANE P IRAULT K EYRUS - B IOPHARMA P HUSE 2010 – B ERLIN](https://reader036.vdocuments.site/reader036/viewer/2022070305/55145757550346284e8b5425/html5/thumbnails/28.jpg)
CONCLUSIONCONCLUSION
INTUITIVE AND EASY TO USE APPLICATION INTUITIVE AND EASY TO USE APPLICATION
AVAILABLE FOR EVERYONEAVAILABLE FOR EVERYONE
EVOLUTIVE SOLUTIONEVOLUTIVE SOLUTION
ALLOWS AN OVERVIEW AT EACH STEP OF THE PROJECT ALLOWS AN OVERVIEW AT EACH STEP OF THE PROJECT
CONSISTENT WITH SECURITIES PRE-REQUISITESCONSISTENT WITH SECURITIES PRE-REQUISITES
ALLOWS SPONSOR ACCESSALLOWS SPONSOR ACCESS
![Page 29: P ROJECT MANAGEMENT (D ASHBOARD AND M ETRICS ) WITH Q LIK V IEW S TÉPHANE P IRAULT K EYRUS - B IOPHARMA P HUSE 2010 – B ERLIN](https://reader036.vdocuments.site/reader036/viewer/2022070305/55145757550346284e8b5425/html5/thumbnails/29.jpg)